Enrofloxacin monohydrochloride is an effective antibiotic used against Mycoplasma bovis (MIC90 = 0.312 μg/mL); it is applied for the treatment of pneumonia, mastitis, arthritis, and other mycoplasma-associated diseases in cattle; additionally, it has been investigated for its protective effects in murine models of stroke, where both preventive and therapeutic administration improved survival following lung infection.